“This seems like a pretty big deal for Novo Nordisk because…” — The Daily at 15:12
“This seems like a pretty big deal for Novo Nordisk because the company, as you've told us, had spent decades working to develop these drugs. It's just a lot of money and time that Novo had invested. And normally, drug patents give a company like Novo time to, you know, finally reap the benefits of that investment.…”
0:00
22:34